Evidence-based labour ward guidelines for the diagnosis, management and treatment of spontaneous preterm labour

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 5, 2003, Pages 469-478

  Lamont, Ronnie F ^a   Atke, Anders ^b   Van Eyck, Jim ^b   Helmer, Hanns ^c   Ingemarsson, Ingemar ^b   Leduc, Line ^d   Moutquin, Jean Marie ^d   Rizzo, Nicola ^e   Svare, Jens ^f   Wischnik, Arthur ^b   Roura, Cabero ^b   Cabrol, Dominique ^b  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

^b Klinieken Locatie ^*

^c UNIVERSITY OF VIENNA   (Austria)

^d UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; FENOTEROL; FIBRONECTIN; HEXOPRENALINE; INDOMETACIN; KETOROLAC; MAGNESIUM SULFATE; OXYTOCIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SALBUTAMOL; SULINDAC; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

ALGORITHM; BIOSIS; CALCIUM CELL LEVEL; DATA BASE; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EMBASE; ENTEROCOLITIS; EVIDENCE BASED MEDICINE; GESTATIONAL AGE; HEADACHE; HEART PALPITATION; HOSPITAL ADMISSION; HUMAN; INFORMATION PROCESSING; INTRAUTERINE GROWTH RETARDATION; LABOR; LUNG DYSPLASIA; LUNG EDEMA; MALAISE; MATERNAL MORTALITY; MATERNITY WARD; MEDICAL LITERATURE; MEDLINE; MENSTRUAL CYCLE; NAUSEA; NEWBORN INTENSIVE CARE; PATIENT MONITORING; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRACTICE GUIDELINE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RESPIRATORY DISTRESS SYNDROME; RESTLESSNESS; REVIEW; SCISEARCH; SIDE EFFECT; THORAX PAIN; TRANSVAGINAL ECHOGRAPHY; TREATMENT CONTRAINDICATION; TREMOR; ULTRASOUND SCANNER; UTERINE CERVIX DILATATION; UTERUS CONTRACTILITY; UTERUS CONTRACTION; VAGINA SECRETION; VOMITING;

ADRENERGIC BETA-AGONISTS; CALCIUM CHANNEL BLOCKERS; CYCLOOXYGENASE INHIBITORS; EVIDENCE-BASED MEDICINE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; MAGNESIUM SULFATE; OBSTETRIC LABOR, PREMATURE; OXYTOCIN; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TOCOLYSIS;

EID: 0141727879     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/0144361031000153666     Document Type: Review

References (66)

1. Abramov Y., Nadjari M., Weinstein D., Ben-Shachar I., Plotkin V. and Ezra Y. (2000) Indomethacin for preterm labor: a randomised comparison of vaginal and rectal-oral routes. Obstetrics and Gynecology, 95, 482-486.
2. Aghajafari F., Murphy K., Hannah M. and Amankwah K. (2001) Repeated courses of antenatal corticosteroids: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology, 184, S36.
3. Al-Qattan F., Omu A.E. and Labeeb N. (2000) A prospective randomised study comparing nifedipine versus ritodrine for the suppression of preterm labour. Medical Principles and Practice, 9, 164-173.
4. Beall M.H., Edgar B.W., Paul R.H. and Smith-Wallace T. (1985) A comparison of ritodrine, terbutaline and magnesium sulphate for the suppression of preterm labor. American Journal of Obstetrics and Gynecology, 153, 854-859.
5. Besinger R.E. and Iannucci T.A. (1997) Tocolytic therapy. In: Preterm Labour, edited by Elder M.G., Lamont R.F. and Romero R., pp. 243-297. New York, Churchill Livingstone.
6. Bivins H.A., Newman R.B., Fyfe D.A., Campbell B.A. and Stratum S.L. (1993) Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor. American Journal of Obstetrics and Gynecology, 169, 1065-1070.
7. Black R.S., Lees C., Thompson C., Pickles A. and Campbell S. (1999) Maternal and foetal cardiovascular effects of transdermal glyceryl trinitrate and intravenous ritodrine. Obstetrics and Gynecology, 94, 572-576.
8. Bossmar T. (1998) Treatment of preterm labour with the oxytocin and vasopressin antagonist Atosiban. Journal of Perinatal Medicine, 26, 458-465.
9. Campbell D.M. and MacGillivray I. (1997) Maternal physiological responses and birthweight in singleton and twin pregnancies by parity. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 7, 17-24.
10. Chau A.C., Gabert H.A. and Miller J.M. (1992) A prospective comparison of terbutaline and magnesium for tocolysis. Obstetrics and Gynecology, 80, 847-851.
11. Childress C.H. and Katz V.L. (1994) Nifedipine and its indications in obstetrics and gynecology. Obstetrics and Gynecology, 83, 616-624.
12. Costeloe K., Hennessy E., Gibson A.T., Marlow N. and Wilkinson A.R. (2000) The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics, 106, 659-671.
13. Crowley P. (2001) Prophylactic Corticosteroids For preterm Birth [Cochrane Review]. The Cochrane Library, Issue 4. Oxford: Update Software.
14. Crowley P., Chalmers I. and Keirse M.J.N.C. (1990) The effects of corticosteroid administration before preterm delivery: an overview from the evidence from controlled trials. British Journal of Obstetrics and Gynaecology, 97, 11-25.
15. Crowther C.A., Hiller J.E., Doyle L.W. (2003) Magnesium Sulphate for Preventing Preterm Birth in Threatened Preterm Labour [Cochrane Review]. The Cochrane Library, Issue 2, 2003. Oxford: Update Software Ltd.
16. European Atosiban Study Group (2001) The oxytocin antagonist atosiban versus the β-agonist terbutaline in the treatment of preterm labour. Acta Obstetrica et Gynecologica Scandinavica, 80, 413-422.
17. Ferguson J.E., Dyson D.C., Schutz T. and Stevenson D.K. (1990) A comparison of tocolysis with nifedipine or ritodrine: analysis of efficacy and maternal, fetal and neonatal outcome. American Journal of Obstetrics and Gynecology, 163, 105-111.
18. Finnstróm O., Otterblad Olausson P., Sedin G., Serenius F., Svenningsen N., Thiringer K., Tunell R., Wennergven M. and Wesstrom C. (1997) The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta Paediatrica, 86, 503-511.
19. Fisher J.E., Smith R.S., Lagrandeur R. and Lorenz R.P. (1997) Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. Obstetrics and Gynecology, 90, 880-883.
20. French/Australian Atosiban Investigators Group (2001) Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 98, 177-185.
21. Garcia-Velasco J.A. and Gonzalez-Gonzalez A. (1998) A prospective, randomised trial of nifedipine vs ritodrine in threatened preterm labor. International Journal of Gynaecology and Obstetrics, 61, 239-244.
22. Gardner M.O., Owen J., Skelly S. and Hauth J.C. (1996) Preterm delivery after indomethacin: a risk factor for neonatal complications? Journal of Reproductive Medicine, 41, 903-906.
23. Hall M.H., Danielian P. and Lamont R.F. (1997) The importance of preterm birth. In: Preterm Labour, edited by Elder M.G., Lamont R.F. and Romero R., pp. 1-28. New York, Churchill Livingstone.
24. Hearne A.E and Nagey D.A. (2000) Therapeutic agents in preterm labour: tocolytic agents. Clinical Obstetrics and Gynecology, 43, 787-801.
25. Highby K. and Suiter C.R. (1999) A risk-benefit assessment of therapies for premature labour. Drug Safety, 21, 35-56.
26. Hole J.W. and Tressler T.B. (2001) Management of preterm labour. Journal of American Osteopathic Association, 101, S14-S18.
27. Jannet D., Abankwa A., Guyard B., Carbonne B., Marpeau L. and Milliez J. (1997) Nicardipine versus salbutamol in the treatment of premature labor. A prospective randomised study. European Journal of Obstetrics, Gynecology and Reproductive Biology, 73, 11-16.
28. Keirse M.J.N.C. (1995) New perspectives for the effective treatment of preterm labour. American Journal of Obstetrics and Gynaecology, 173, 618-628.
29. King J.F. (2001) Oral nicardipine was as efficacious as magnesium sulfate for treatment of preterm labor, with fewer side-effects. Evidence-based Obstetrics and Gynecology, 3, 71-72.
30. King J.F., Grant A., Keirse M.J. and Chalmers I. (1998) Betamimetics in preterm labour: an overview of the randomised controlled trials. British Journal of Obstetrics and Gynaecology, 95, 211-222.
31. King J.F., Flenady V.J., Papatsonis D.N.M., Dekker G.A., Carbonne B. (2003) How to interpret and utilise the Cochrane Review on calcium channel blockers for inhibiting preterm labour. Cochrane Database Systematic Reviews, Issue 2, Oxford: Update Software Ltd.
32. Koks C.A., Broelmann H.A., de Kleine M.J. and Manger P.A. (1998) A randomized comparison of nifedipine and ritodrine for suppression of preterm labor. European Journal of Obstetrics, Gynecology and Reproductive Biology, 77, 171-176.
33. Kupfermine M., Lessing J.B., Yaron Y. and Peyser M.R. (1993) Nifedipine versus ritodrine for suppression of preterm labour. British Journal of Obstetrics and Gynaecology, 100, 1090-1094.
34. Lammintausta R. and Erkkola R. (1979) Effect of long term salbutamol treatment on renin aldosterone system in twin pregnancy. Acta Obstetricia et Gynaecologica Scandinavica, 58, 447-451.
35. Lamont R.F. (2000) The pathophysiology of pulmonary oedema with the use of beta-agonists. British Journal of Obstetrics and Gynaecology, 107, 439-444.
36. Lamont R.F., Dunlop P.D., Crowley P., Levene M.I. and Elder M.G. (1983) Comparative mortality and morbidity of infants transferred in utero or postnatally. Journal of Perinatal Medicine, 11, 200-203.
37. Lees C.C., Lojacono A., Thompson C., Danti L., Black R.S., Tanzi P., White R. and Campbell S. (1999) Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomised study. Obstetrics and Gynecology, 94, 403-408.
38. Lockwood C.J., Senyel A.E., Dische M.R., Casal D., Shah K.D., Thung S.N., Jone S., Deligdisc L. and Garite J.J. (1991) Foetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. New England Journal of Medicine, 325, 669-674.
39. Lopez-Bernal A. and TambyRaja R.L. (2000) Preterm labour. Baillière's Best Practice and Research. Clinical Obstetrics and Gynaecology, 14, 133-153.
40. Magowan R.A., Pain M., Juszczak B.E. and McInnery K. (1999) Neonates mortality among Scottish preterm singleton births. Neonatal Intensive Care, 12, 47-50.
41. Merrill J.D., Clyman R.I. and Norton M.E. (1994) Indomethacin as a tocolytic agent: the controversy continues. Journal of Pediatrics, 124, 734-736.
42. Mittendorf R., Covert R., Boman J., Khoshnood B., Lee K.S. and Siegler M. (1997) Is tocolytic magnesium sulphate associated with increased total paediatric mortality? Lancet, 350, 1517-1518.
43. Morales W.J. and Madhav H. (1993) Efficacy and safety of indomethacin compared with magnesium sulphate in the management of preterm labour: a randomized study. American Journal of Obstetrics and Gynecology, 169, 97-102.
44. Moutquin J.M., Sherman D., Cohen H., Mohide P.T., Hochner-Celnikier D., Fejgin M., Liston R.M., Dansgreau J., Mazor M., Shalev E., Boucher M., Glezerman M., Zimmer E. and Rabinovici I.N. (2000) Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labour: a multicenter effectiveness and safety study. American Journal of Obstetrics and Gynecology, 182, 1191-1199.
45. National Institutes of Health Consensus Development Panel (2001) Antenatal corticosteroids revisited; repeat courses. Obstetrics and Gynecology, 98, 144-150.
46. National Institutes of Health Consensus Statement (1994) Effect of Corticosteroids for Foetal Maturation on Perinatal Outcome, Vol. 12, No. 2: 28 February-2 March.
47. Papatsonis D.N., Van-Geijn H.P., Ader H.J., Lange F.M., Bicker O.P. and Dekker G.A. (1997) Nifedipine and ritodrine in the management of preterm labor: a randomised multicenter trial. Obstetrics and Gynecology, 90, 230-234.
48. Papatsonis D.N.M., Kok J.H., Van-Geijn H.P., Bleker O.P., Ader H.J. and Dekker G.A. (2000) Neonatal effects of nifedipine and ritodrine for preterm labor. Obstetrics and Gynecology, 95, 477-481.
49. Papatsonis D.N.M., Lok C.A.R., Bos J.M., Geijn H.P. and Dekker G.A. (2001) Calcium channel blockers in the management of preterm labour and hypertension in pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 97, 122-140.
50. Romero R., Sibai B.M., Sanchez-Ramos L., Valenzuela G.J., Veille J., Tabor B., Perry K.J., Varner M., Goodwin T.M., Lane R., Smith J., Shangold G. and Creasy G.W. (2000) An oxytocin receptor antagonist (atosiban) in the treatment of preterm labour: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. American Journal of Obstetrics and Gynecology, 182, 1173-1183.
51. Royal College of Obstetricians and Gynaecologists (1997) Beta-agonists for the care of women in preterm labour. Guideline 1A, January. London, RCOG Press.
52. Rozenberg P. (2001) Tocolysis, use of beta-sympathomimetics for threatening preterm delivery: a critical review. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 30, 221-230.
53. Rozenberg P., Goffinet F. and Hessabi M. (1999) Comparison of the Bishop score, of sonographic measurement of the cervical length and fibronectin determination in predicting time to delivery and the type of delivery at term. Bulletin de l'Academie Nationale de Medecine, 183, 589-599.
54. Rozenberg P., Goffinet F., Malagrida L., Giudicelli Y., Perdu M., Houssin I. et al. (1997) Evaluating the risk of preterm delivery: a comparison of foetal fibronectin and transvaginal ultrasonographic measurement of cervical length. American Journal of Obstetrics and Gynecology, 176, 196-199.
55. Schmitz T., Goffinet F., Jarreau P.H., Moriette G. and Cabrol D. (2000) Repetition of corticoid treatment for foetal lung maturation: clinical and experimental scientific data. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 29, 458-468.
56. Schorr S.J., Ascarelli M.H., Rust O.A., Ross E.L., Calfee E.L., Perry K.G. and Morrison J.C. (1998) A comparative study of ketorolac (Toradol) and magnesium sulfate for arrest of preterm labor. Southern Medical Journal, 91, 1028-1032.
57. Scudiero R., Khoshnood B., Pryde P.G., Lee K.S., Wall S. and Mittendorf R. (2000) Perinatal death and tocolytic magnesium sulphate. Obstetrics and Gynecology, 96, 178-182.
58. Sibony O., de Gayffier A. and Carbillon L, (1994) Has the use of indomethacin during pregnancy consequences newborn infants? Prospective study of 83 pregnant women and 115 newborn infants. Archives de Pediatrie, 1, 709-715.
59. Spisso K.R., Harbert G.M. Jr and Thiagarajah S. (1982) The use of magnesium sulfate as the primary tocolytic agent to prevent premature delivery. American Journal of Obstetrics and Gynecology, 142, 840-845.
60. Tsatsaris V., Carbonne B. (2001) Tocolysis with calcium channel blockers. Journal de Gynécologie Obstétrique et Biologie de la Reproduction (Paris), 30, 246-251.
61. Vause S. and Johnston T. (2000) Management of preterm labour. Archives of Disease in Childhood, Fetal and Neonatal Edition, 83, F79-F85.
62. Vermillion S.T., Soper D.E. and Newman R.B. (2000) Neonatal sepsis and death after multiple courses of antenatal betamethasone therapy. American Journal of Obstetrics and Gynecology, 183, 810-814.
63. Wood N.S., Marlow M., Costeloe K., Gibson A.T. and Wilkinson A.R. (2000) Neurologic and developmental disability after extremely preterm birth. New England Journal of Medicine, 343, 378-384.
64. Woolf S.H., Grol R., Hutchinson A., Eccles M.P. and Grimshaw J.M. (1999) The potential benefits, limitations and harms of clinical guidelines. British Medical Journal, 318, 527-530.
65. World Health Organization (1993) International Statistical Classification of Diseases and Related Health Problems, 10th revision, Vol. 2. Geneva, Switzerland: WHO.
66. Worldwide Atosiban versus Beta-agonists Study Group (2001) Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. British Journal of Obstetrics and Gynaecology, 108, 133-142.